European nations sign with Astrazeneca for vaccine

Italy, Germany, France and the Netherlands have signed a contract with the British-Swedish pharmaceutical firm Astrazeneca for up to 400 million doses of a vaccine developed by the University of Oxford, the company said on Saturday. The first batch would be made available to European citizens by the end of 2020, according to the Reuters news agency.